APA (7th ed.) Citation

TA, T., S, O., O, A., N, F., MA, O., N, S., . . . PF, Y. (2022). Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment. Annals of nuclear medicine, 36(11), 964. https://doi.org/10.1007/s12149-022-01785-x

Chicago Style (17th ed.) Citation

TA, Telli, et al. "Role of Baseline 68Ga-PSMA PET/CT-derived Whole-body Volumetric Parameters in Predicting Survival Outcomes of Metastatic Castration-resistant Prostate Cancer Patients Receiving First-line Treatment." Annals of Nuclear Medicine 36, no. 11 (2022): 964. https://doi.org/10.1007/s12149-022-01785-x.

MLA (9th ed.) Citation

TA, Telli, et al. "Role of Baseline 68Ga-PSMA PET/CT-derived Whole-body Volumetric Parameters in Predicting Survival Outcomes of Metastatic Castration-resistant Prostate Cancer Patients Receiving First-line Treatment." Annals of Nuclear Medicine, vol. 36, no. 11, 2022, p. 964, https://doi.org/10.1007/s12149-022-01785-x.